Periodic Reporting for period 1 - 2LIVEr (IL-2 gene therapy for chronic hepatitis B virus infection)

Approximately two billion people worldwide have evidence of past or present infection with hepatitis B virus (HBV), and 350-400 million individuals are chronic carriers (i.e., positive for hepatitis B surface antigen HBsAg). Conventional treatments are based on antiretroviral...